Identifying Drug‐Related ReadmissionsIs There a Better Way of Assessing the Contribution of Adverse Medication Events?

To evaluate previously reported approaches (review of International Classification of Diseases 9th edition ‐9] and diagnosis related group ] codes, and review of medical files) and a new method (review of recent medication changes) of assessing the contribution of adverse drug events (ADEs) to unplanned readmissions.